NCT02393794 2025-10-06Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)University of Kansas Medical CenterPhase 1/2 Active not recruiting51 enrolled